Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

High rate of ileo-colonic lymphoid nodular hyperplasia in autism

Ileo-colonic lymphoid nodular hyperplasia is a characteristic pathological finding in children with ASD and gastrointestinal symptoms, reports the most recent issue of the European Journal of Gastroenterology & Hepatology.

News image

fiogf49gjkf04

Intestinal mucosal pathology is characterized by ileo-colonic lymphoid nodular hyperplasia, mild acute and chronic inflammation of the colorectum, small bowel and stomach.

It has been reported in children with autistic spectrum disorder.

Dr Andrew Wakefield and colleagues assessed ileo-colonic lymphoid nodular hyperplasia in autistic spectrum disorder and control children.

The research team tested the hypothesis that there is an association between ileo-colonic lymphoid nodular hyperplasia and autistic spectrum disorder in children.

The team included 148 consecutive children with autistic spectrum disorder, of which 127 were male with gastrointestinal symptoms with a median age of 6 years.

Gastrointestinal symptoms were investigated by ileo-colonoscopy.

The researchers scored and compared macroscopic and histological features of different groups.

Ileal lymphoid nodular hyperplasia occurred in 90% with autistic spectrum disorder vs 30% in controls
European Journal of Gastroenterology & Hepatology

Group 1 included 30 developmentally normal controls, of which 25 were males with median age of 7 years with no inflammatory bowel disease or celiac disease.

The team reported that Group 2 included 16 cases showing mild non-specific colitis, of which 13 were male.

Group 3 included 14 cases with normal colonic histology, of which 12 were male.

The researchers reported that from these groups, 74 children with autistic spectrum disorder and 23 controls underwent upper gastrointestinal endoscopy.

The influence on ileal lymphoid nodular hyperplasia of dietary restriction, and age at colonoscopy was examined.

In addition, the team examined co-existent lymphoid nodular hyperplasia elsewhere in the intestine.

The researchers found that the prevalence of lymphoid nodular hyperplasia in the ileum was 90% with autistic spectrum disorder compared with 30% controls.

Lymphoid nodular hyperplasia in the colon occurred more often in the group with autistic spectrum disorder, at 59% versus controls at 23%.

The researchers found that these results persisted whether or not controls had co-existent colonic inflammation.

The severity of ileal lymphoid nodular hyperplasia was significantly greater in children with autistic spectrum disorder compared with controls.

The research team observed that moderate to severe ileal lymphoid nodular hyperplasia was present in 68% of children with autism versus 15% in controls .

The team noted that severe ileal lymphoid nodular hyperplasia was associated with co-existent colonic lymphoid nodular hyperplasia in children with autism.

However, the presence and severity of ileal lymphoid nodular hyperplasia was not influenced by either diet or age at colonoscopy.

The team noted that isolated ileal lymphoid nodular hyperplasia without evidence of pathology elsewhere in the intestine occurred in less than 3% of children.

On histopathological examination, hyperplastic lymphoid follicles were found to be more prevalent in the ileum of children with autistic spectrum disorder versus controls.

Dr Wakefield's team concluded, “Ileo-colonic lymphoid nodular hyperplasia is a characteristic pathological finding in children with autistic spectrum disorder and gastrointestinal symptoms.”

“It is associated with mucosal inflammation, and differences in age at colonoscopy and diet do not account for these changes.”

“The data support the hypothesis that lymphoid nodular hyperplasia is a significant pathological finding in children with autistic spectrum disorder.”

Eur J Gastroenterol & Hepatol 2005: 17(8): 827-36
13 July 2005

Go to top of page Email this page Email this page to a colleague

 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD
 13 December 2017 
Tryptophan metabolism and IBD activity
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us